Gastrointestinal Oncology ServiceFeed

People

  1. Epstein
    Epstein
  2. Raj
    Raj
  3. Li
    Li
  4. Bielska
    Bielska
  5. Khalil
    Khalil
  6. Nusrat
    Nusrat
  7. Ku
    Ku
  8. Shcherba
    Shcherba
  9. Reidy
    Reidy
  10. White
    White
  11. Yang
    Yang
  12. Kemeny
    Kemeny
  13. Connell
    Connell
  14. Saltz
    Saltz
  15. Janjigian
    Janjigian

Description

Publications

  1. Journal of Clinical Oncology (1002)
  2. Annals of Oncology (208)
  3. Cancer (118)
  4. Annals of Surgical Oncology (85)
  5. Clinical Cancer Research (85)
  6. Cancer Research (70)
  7. Journal of the National Comprehensive Cancer Network (66)
  8. International Journal of Radiation Oncology, Biology, Physics (48)
  9. Pancreas (48)
  10. European Journal of Cancer (41)

Publishers

  1. American Society of Clinical Oncology (1053)
  2. Elsevier Inc. (335)
  3. Oxford University Press (258)
  4. Springer (235)
  5. Wiley Blackwell (199)
  6. Lippincott Williams & Wilkins (159)
  7. Elsevier Science, Inc. (110)
  8. Nature Publishing Group (86)
  9. American Association for Cancer Research (84)
  10. American Association for Cancer Research (70)

Belongs to

Types of Work

Ajax loader

Recent Works

  1. Transcriptomic profiling to identify subsets of immune hot locally advanced rectal adenocarcinomas with favorable outcomes after neoadjuvant treatment
    Meeting Abstract

    Sanchez Vega, F.; Chatila, W. K.; Kim, J. K.; Walch, H. S.; Marco, M.; Chen, C. T.; Wu, F.; Khalil, D.; Ganesh, K.; Qu, X.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  2. Real-world clinical outcomes of patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) treated with liposomal irinotecan-based regimens: Impact of prior irinotecan (IRI) exposure
    Meeting Abstract

    Yu, K. H.; Cockrum, P.; Surinach, A.; Lamarre, N.; Wang, S.; O'Reilly, E. M.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  3. Zolbetuximab + CAPOX versus CAPOX in first-line treatment of claudin18.2(+)/HER2(-) advanced/metastatic gastric or gastroesophageal junction adenocarcinoma: GLOW phase 3 study
    Meeting Abstract

    Shah, M. A.; Ajani, J. A.; Al-Batran, S. E.; Bang, Y. J.; Catenacci, D. V. T.; Enzinger, P. C.; Ilson, D. H.; Kim, S. S.; Lordick, F.; Shitara, K.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save